Autobio Diagnostics Co., Ltd. (SHA:603658)
34.35
+0.90 (2.69%)
Apr 1, 2026, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 19.11 billion as of March 31, 2026. Its market cap has decreased by -19.46% in one year.
Market Cap
19.11B
Enterprise Value
18.40B
Revenue
4.22B
Ranking
n/a
PE Ratio
17.43
Stock Price
34.35
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 19.11B, an increase of 116.71%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 19.11B | -5.56% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 33.92B |
| Lepu Medical Technology (Beijing) | 29.33B |
| MGI Tech | 20.66B |
| Double Medical Technology | 17.50B |
| Shandong Weigao Blood Purification Products | 15.62B |
| MeHow Innovative | 14.48B |
| Jafron Biomedical | 13.72B |
| Beijing Balance Medical Technology | 13.46B |